Anti-endotoxic, antimicrobial cationic peptides and methods...

Details Anti-endotoxic, antimicrobial cationic peptides and methods... Anti-endotoxic, antimicrobial cationic peptides and methods...

1998-08-28

2001-09-11

Carlson, Karen Cochrane (Department: 1653)

Chemistry: natural resins or derivatives; peptides or proteins;

Peptides of 3 to 100 amino acid residues

C530S324000, C530S325000, C530S327000, C435S069100, C514S012200, C514S013800

Reexamination Certificate

active

06288212

ABSTRACT:

BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates generally to antimicrobial peptides and specifically to antimicrobial cationic peptides useful for overcoming antibiotic resistance and effective as therapeutics for pathologies resulting from microbial infections.
2. Description of Related Art
In 1981, the self-promoted uptake hypothesis was first proposed to explain the mechanism of action of polycationic antibiotics in
Pseudomonas aeruginosa.
According to this hypothesis, polycations interact with sites on the outer membranes of Gram-negative bacteria at which divalent cations cross-bridge adjacent lipopolysaccharide molecules. Due to their higher affinity for these sites, polycations displace the divalent cations and, since the polycations are bulkier than the divalent cations, cause structural perturbations in the outer membrane. These perturbations result in increased outer membrane permeability to compounds such as the &bgr;-lactam antibiotic nitrocefin, the eukaryotic non-specific defense protein lysozyme and to hydrophobic substances. By analogy, molecules accessing this pathway are proposed to promote their own uptake.
It has been clearly demonstrated that the outer membranes of Gram-negative bacteria are semipermeable molecular “sieves” which restrict access of antibiotics and host defense molecules to their targets within the bacterial cell. Thus, cations and polycations which access the self-promoted uptake system are, by virtue of their ability to interact with and break down the outer membrane permeability barrier, capable of increasing the susceptibility of Gram-negative pathogenic bacteria to antibiotics and host defense molecules. Hancock and Wong demonstrated that a broad range of such compounds could overcome the permeability barrier and coined the name “permeabilizers” to describe them (Hancock and Wong,
Antimicrob. Agents Chemother.,
26:48, 1984). While self-promoted uptake and permeabilizers were first described for
P. aeruginosa,
they have now been described for a variety of Gram-negative bacteria.
Over the past decade, non-specific defense molecules have been described in many animals, including insects and humans. One subset of these molecules have in common the following features: (a) they are small peptides, usually 15-35 amino acids in length, (b) they contain 4 or more positively charged amino acid residues, either lysines or arginines, and (c) they are found in high abundance in the organisms from which they derive. Several of these molecules have been isolated, amino acid sequenced and described in the patent literature (e.g., cecropins: WO8900199, WO 8805826, WO8604356, WO 8805826; defensins: EP 193351, EP 85250, EP 162161, U.S. Pat. No. 4,659,692, WO 8911291). However, only limited amounts of these peptides can be isolated from the host species. For example, Sawyer, et al., (
Infect. Immun.
56:693, 1988) isolated 100-200 mg of rabbit neutrophil defensins 1 and 2 from 10
9
primed peritoneal neutrophils or lipopolysaccharide-elicited alveolar macrophages (i.e., the numbers present in a whole animal).
Some cationic antibacterial peptides are of relatively high molecular weight (greater than about 25 kDa) and are effective against certain Gram negative bacteria such as
Escherichia coli, Salmonella typhimurium
and
Pseudomonas aeruginosa
by damaging the cytoplasmic membrane leading to increased membrane permeability. Human bactericidal/permeability increasing protein (BPI) is a strongly basic protein with a molecular weight of about 59 kDa. It is believed that, when bound to outer membrane of the susceptible bacterial cells, hydrophobic channels through the outer envelope are exposed, and as a secondary effect, there is a selective activation of autolytic enzymes including phospholipase and peptidoglycan hydrolases. Gram positive bacteria, certain Gram negative bacteria and fungi are not affected by BPI in vitro. Low molecular weight cationic peptides (10 kDa to 25 kDa) have been reported which inhibit the growth of such Gram positive bacteria as
Staphylococcus aureus
(Root and Cohen,
Rev. Infect. Dis.,
3:565-598, 1981). In addition cationic peptides with fungicidal activity have been identified in alveolar macrophages. It is believed that cationic peptides are most efficient in killing phagocytized microorganisms in combination with other microbicidal defense mechanisms.
Generally defensins are relatively small polypeptides of about 3-4 kDa, rich in cysteine and arginine. Gabay et al. (
Proc. Natl. Acad. Sci. USA,
86:5610-5614, 1989) used reversed phase HPLC to purify 12 major polypeptides from the azurophil granules of human polymorphonuclear leukocytes (PMNs). Defensins as a class have activity against some bacteria, fungi and viruses. The defensins are believed to have a molecular structure stabilized by cysteine infrastructure, which are essential for biological activity. The gene for human defensin has been cloned and sequenced, but no successful expression has been demonstrated, as yet. Furthermore, production of these peptides using peptide synthesis technology produces peptides in limited amounts and is expensive when scaled up or when many variant peptides must be produced. Also, structural analysis is difficult without specific incorporation of
15
N and
13
C tagged amino acids which is prohibitively expensive using amino acid synthesis technology.
Another class of antimicrobial peptides are those known as magainins and at least five of which can be isolated from the African clawed frog (
Xenopus laevis
). The natural proteins are active against a broad range of microorganisms including bacteria, fungi and protozoans (Zasloff,
Proc. Natl. Acad. Sci., USA,
84:5499, 1987). The broad spectrum antimicrobial activity is present in synthetic peptides and in certain truncated analogs of the natural proteins. Derivatives of about 19 to about 23 amino acids have antibacterial activity as measured using
Escherichia coli.
In addition, the antimicrobial activity of magainin appears to result in the disruption of the membrane functions of Paramecium caudatum. The configurations of the bioactive peptides can be modeled as amphophilic alpha-helices and are sufficiently long to span a lipid bilayer (Zasloffet al.,
Proc. Natl. Acad. Sci., USA,
85:91988). Spanning a lipid bilayer is believed to require at least twenty amino acid residues in an alpha-helical configuration (Kaiser,
Ann. Rev. Biophys. Chem.,
16:562, 1987)
Cationic peptides containing a disulphide bond forming a looped structure were recently identified (Morikawa et al.,
Biochim. Biophys. Res. Commun.
189:184, 1992; Simmaco et al.,
FEBS
324:159, 1993; Clark et al.,
J. Biol. Chem.
269:10849, 1994). One member of this group, bactenecin (i.e., dodecapeptide), is a twelve amino acid peptide isolated from bovine neutrophils (Romeo et al.,
J. Biol. Chem.
263:9573, 1988). Bactenecin is the smallest known cationic antimicrobial peptide. Two cysteine residues form a disulphide bond to make bactenecin a loop molecule. Bactenecin was previously found to be active against
Escherischia coli
and
Staphylococcus aureus,
and strongly cytotoxic for rat embryonic neurons, fetal rat astrocytes and human glioblastoma cells (Radermacher et al.,
J. Neuroscience Res.
36:657, 1993).
Synthetic peptide chemistry has determined that a-helices are a common structural motif found in both antibacterial peptides that can act selectively on bacterial membranes (e.g., cecropin), and in cytotoxic peptides that can lyse both mammalian and bacterial cells (e.g., melittin). Cecropins were initially discovered in insects but later found in other animals including mammals. Electron microscopy has revealed that cecropin-induced inhibition of bacterial growth is due, in part, to bacterial wall lysis. Resistance to such a generally destructive mechanism may prove difficult for some microbial pathogens, as compared with the more specific mechanisms of the currently used antibiotics. Further, the bee venom peptide melittin is known to form channel-like structures in biolo

Affiliated with

Also associated with

Rating

Anti-endotoxic, antimicrobial cationic peptides and methods... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-endotoxic, antimicrobial cationic peptides and methods..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-endotoxic, antimicrobial cationic peptides and methods... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2463728